Hilton Head Capital Partners, LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 2109913
HILTON HEAD ISLAND, SC
Position in TAK
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,612
-$406 QoQ
Shares Held
163
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#326
of 375 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hilton Head Capital Partners, LLC holds $195,796 across 9 Drug Manufacturers - Specialty & Generic names. TAK ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,756 | $93,373 | |
| 2 | LQDA |
Liquidia Corp
|
500 | $39,865 | |
| 3 | VTRS |
Viatris Inc
|
1,185 | $18,817 | |
| 4 | TLRY |
Tilray Brands, Inc.
|
3,766 | $16,909 | |
| 5 | HLN |
Haleon plc
|
1,447 | $13,500 | |
| 6 | ZTS |
Zoetis Inc.
|
125 | $8,982 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
163 | $2,612 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
50 | $1,733 |
All Filings in TAK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,612 | 163 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,018 | 163 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,541 | 163 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||